T. Rowe Price Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,074,699
Closed -$577M 2622
2018
Q3
$577M Buy
6,074,699
+3,370,668
+125% +$287M 0.08% 238
2018
Q2
$209M Buy
2,704,031
+408,155
+18% +$30.6M 0.03% 471
2018
Q1
$159M Buy
2,295,876
+97,625
+4% +$7.45M 0.03% 516
2017
Q4
$164M Buy
2,198,251
+1,137,814
+107% +$72.8M 0.03% 501
2017
Q3
$67.1M Sell
1,060,437
-91,877
-8% -$5.71M 0.01% 744
2017
Q2
$73.6M Sell
1,152,314
-124,701
-10% -$7.83M 0.01% 696
2017
Q1
$84.2M Sell
1,277,015
-64,814
-5% -$4.46M 0.02% 642
2016
Q4
$92.3M Sell
1,341,829
-5,901
-0.4% -$423K 0.02% 622
2016
Q3
$95.1M Buy
1,347,730
+16,620
+1% +$1.24M 0.02% 588
2016
Q2
$101M Sell
1,331,110
-72,965
-5% -$5.36M 0.02% 561
2016
Q1
$96.4M Buy
1,404,075
+1,381
+0.1% +$99.3K 0.02% 563
2015
Q4
$123M Sell
1,402,694
-22,902
-2% -$1.96M 0.03% 509
2015
Q3
$115M Sell
1,425,596
-72,821
-5% -$6.34M 0.03% 530
2015
Q2
$133M Sell
1,498,417
-25,340
-2% -$2.21M 0.03% 528
2015
Q1
$132M Buy
1,523,757
+17,786
+1% +$1.49M 0.03% 535
2014
Q4
$128M Sell
1,505,971
-48,390
-3% -$3.78M 0.03% 547
2014
Q3
$110M Sell
1,554,361
-200,801
-11% -$14.3M 0.02% 582
2014
Q2
$122M Sell
1,755,162
-2,576,713
-59% -$181M 0.03% 573
2014
Q1
$325M Sell
4,331,875
-2,450,497
-36% -$183M 0.07% 315
2013
Q4
$476M Sell
6,782,372
-2,920,113
-30% -$191M 0.11% 222
2013
Q3
$599M Sell
9,702,485
-100,218
-1% -$6.48M 0.15% 177
2013
Q2
$605M Buy
+9,802,703
New +$590M 0.16% 164

Other funds holding ESRX

T. Rowe Price Associates's ESRX Position: Q4 2018 in Review

T. Rowe Price Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 6,074,699 shares — an estimated $577M sold.

T. Rowe Price Associates first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $605M in Q2 2013. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • T. Rowe Price Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 6,074,699 Express Scripts Holding Company shares in Q4 2018, an estimated $577M.
  • T. Rowe Price Associates first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • T. Rowe Price Associates's Express Scripts Holding Company position peaked at $605M in Q2 2013.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.